We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

A picture of Alison Halliday, PhD

Alison Halliday, PhD profile page

Dr. Alison Halliday is an award-winning freelance science communications specialist with 20+ years of experience across academia, industry and the third sector – including ten years at the world’s largest cancer charity. She is skilled at translating complex information into jargon-free, engaging, stories – specializing in topics across the life sciences, medicine and health. After completing her PhD in molecular genetics at the University of Newcastle, she carried out five years of postdoctoral research at University College London before moving into science communications. She now works with a variety of clients to bring their research to life – including companies that need support with their product marketing, or organizations looking to engage with their audiences about the latest advances in biomedicine.

Got a Question for Alison Halliday, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content
Total: 43
Targeting TGF-β Signaling in Cancer: A Double-edged Sword content piece image

Targeting TGF-β Signaling in Cancer: A Double-edged Sword

Transforming growth factor (TGF)-β signaling is an attractive therapeutic target as it is deregulated in many cancers. But challenges remain around developing inhibitors that can specifically block tumor-promoting activities while preserving its tumor suppressive effects.
A female scientist.

A Renaissance for Microflow Liquid Chromatography Mass Spectrometry?

First developed in the 1970s, recent developments are making microflow liquid chromatography techniques more robust – enticing researchers to revisit the opportunities it offers for more sensitive, high-throughput analyses requiring smaller sample volumes than standard flow techniques.

Exploiting Epigenetics in Cancer Treatment

Changes to the complex of DNA and the proteins that form chromatin are important drivers in many cancers. We explore the challenges and progress in the development of new therapies targeting epigenetic regulators.

Cancer Biomarkers: the Liquid Biopsy Revolution

Non-invasive liquid biopsies are set to change the landscape of how cancers are diagnosed and treated in the future. We explore how mass spectrometry is helping researchers discover protein biomarkers in blood and urine, highlight challenges around their validation – and find out how close they are to reaching the clinic.
X-ray Crystallography: Exploring the Frontiers of Structural Biology content piece image

X-ray Crystallography: Exploring the Frontiers of Structural Biology

For over a century, X-ray crystallography has enabled scientists to elucidate biological structures in exquisite detail. Now, powerful new technologies are bringing unprecedented opportunities to add to the history of breakthroughs in this cutting-edge field.

Metabolomics: The Long Journey from Lab to Clinic

Recent improvements in technology are enabling the simultaneous detection and quantitation of large numbers of metabolites from biological samples. Here, we examine the challenges and innovations in metabolomics technologies and find out how these tools are impacting on clinical biomarker discovery.
Metagenomics: Exploring Microbiomes at Nature’s New Frontiers   content piece image

Metagenomics: Exploring Microbiomes at Nature’s New Frontiers

Advances in sequencing technologies are providing scientists with a powerful way to view microbial communities in unprecedented detail. Metagenomics is a rapidly evolving field that is uncovering a wealth of hidden biodiversity, revolutionizing our understanding of uncharted corners in the living world.

Proteomics and Cancer: A Powerful New Revolution

In the post-genomics era, we look at the powerful new revolution in proteomics. We find out how advances are deepening our understanding of cancer biology and resistance processes, which will lead to new clinical applications such as non-invasive biomarkers and drug development.

Exploiting Exosomes for Cancer Diagnosis and Treatment

Evidence is mounting for exosomes playing a central role in many aspects of cancer biology. As researchers start to unravel the secrets of these elusive little vesicles, this is opening a host of exciting new opportunities to tackle cancer – from non-invasive diagnostics to innovative new therapeutics.

Making Medicine More Precise Using Metabolomics

The metabolome is exquisitely sensitive to our physiology, sitting at the interface of our genome and environment. Developing handheld devices that enable people to monitor themselves for changes in their metabolites that can predict future disease will empower them to take charge of their own healthcare, transforming medicine.